A Randomized, Two-period Crossover Trial Examining Bioequivalence of Bisoprolol-Amlodipine 5 mg/5 mg Combination Tablets Versus Bisoprolol 5 mg Tablets and Amlodipine 5 mg Tablets Given Concomitantly in Healthy Subjects in Fasting and Fed State
Phase of Trial: Phase I
Latest Information Update: 28 Sep 2017
At a glance
- Drugs Amlodipine/bisoprolol (Primary) ; Amlodipine; Bisoprolol
- Indications Essential hypertension
- Focus Pharmacokinetics
- Sponsors Merck KGaA
- 25 Sep 2017 Status changed from recruiting to completed.
- 04 Sep 2017 Status changed from not yet recruiting to recruiting.
- 25 Jul 2017 New trial record